The results of our study suggest that TM7SF2/C-Raf/ERK1/2 axis exerts an essential effect on the progression of cervical cancer and targeting TM7SF2 may be a promising method to treat cervical cancer. This evidence concerns the gene TM7SF2 and cervical cancer.